Characteristics associated with citation rate of the medical literature

PLoS ONE

Volumn 2, Issue 5, 2007, Pages

  Kulkarni, Abhaya V ^a   Busse, Jason W ^b   Shams, Iffat ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CITATION ANALYSIS; COHORT ANALYSIS; CONFIDENCE INTERVAL; MEDICAL LITERATURE; MULTIVARIATE ANALYSIS; ONCOLOGY; PUBLICATION; REGRESSION ANALYSIS; UNIVARIATE ANALYSIS; WRITING; JOURNAL IMPACT FACTOR;

CONFIDENCE INTERVALS; JOURNAL IMPACT FACTOR; LEAST-SQUARES ANALYSIS;

EID: 41649110880     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000403     Document Type: Article

References (25)

1. Garfield E (1996) How can impact factors be improved? BMJ 313: 411-413.
2. Gotzsche PC (1987) Reference bias in reports of drug trials. BMJ 295: 654-656.
3. Schmidt LM, Gotzsche PC (2005) Of mites and men: reference bias in narrative review articles: a systematic review. J Fam Pract 54: 334-338.
4. Ravnskov U (1992) Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. BMJ 305: 15-19.
5. Ravnskov U (1995) Quotation bias in reviews of the diet-heart idea. J Clin Epidemiol 48: 713-719.
6. Callaham M, Wears RL, Weber E (2002) Journal prestige, publication bias, and other characteristics associated with citation of published studies in peer-reviewed journals. JAMA 287: 2847-2850.
7. Phillips DP, Kanter EJ, Bednarczyk B, Tastad PL (1991) Importance of the lay press in the transmission of medical knowledge to the scientific community. N Engl J Med 325: 1180-1183.
8. Healy D, Cattell D (2003) Interface between authorship, industry and science in the domain of therapeutics. Br J Psychiatry 183: 22-27.
9. Olson CM (1994) Publication bias. Acad Emerg Med 1: 207-209.
10. Bekelman JE, Li Y, Gross CP (2003) Scope and impact of financial conflicts of interest in biomedical research: A systematic review. JAMA 289: 454-465.
11. Lesser LI, Ebbeling CB, Goozner M, Wypij D, Ludwig DS (2007) Relationship between funding source and conclusion among nutrition-related scientific articles. PLoS Med 4: e5.
12. Belsley DA, Kuh E, Welsch RE (1980) Regression Diagnostics: Identifying Influential Data and Sources of Collinearity. New York: John Wiley & Sons.
13. Dickersin K, Scherer R, Suci ES, Gil-Montero M (2002) Problems with indexing and citation of articles with group authorship. JAMA 287: 2772-2774.
14. MacKinnon L, Clarke M (2002) Citation of group-authored papers. Lancet 360: 1513-1514.
15. Gami AS, Montori VM, Wilczynski NL, Haynes RB (2004) Author self-citation in the diabetes literature. CMAJ 170: 1925-1927.
16. Fassoulaki A, Paraskeva A, Papilas K, Karabinis G (2000) Self-citations in six anaesthesia journals and their significance in determining the impact factor. Br J Anaesth 84: 266-269.
17. Garfield E, Welljams-Dorof A (1992) Of Nobel class: a citation perspective on high impact research authors. Theor Med 13: 117-135.
18. Lee KP, Schotland M, Bacchetti P, Bero LA (2002) Association of journal quality indicators with methodological quality of clinical research articles. JAMA 287: 2805-2808.
19. Weeks WB, Wallace AE, Kimberly BC (2004) Changes in authorship patterns in prestigious US medical journals. Soc Sci Med 59: 1949-1954.
20. Als-Nielsen B, Chen W, Gluud C, Kjaergard LL (2003) Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA 290: 921-928.
21. Bhandari M, Busse JW, Jackowski D, Montori VM, Schunemann H, et al. (2004) Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ 170: 477-480.
22. Kjaergard LL, Als-Nielsen B (2002) Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ 325: 249-252.
23. Friedberg M, Saffran B, Stinson TJ, Nelson W, Bennett CL (1999) Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA 282: 1453-1457.
24. Djulbegovic B, Lacevic M, Cantor A, Fields KK, Bennett CL, et al. (2000) The uncertainty principle and industry-sponsored research. Lancet 356: 635-638.
25. Patsopoulos NA, Ioannidis JP, Analatos AA (2006) Origin and funding of the most frequently cited papers in medicine: database analysis. BMJ 332: 1061-1064.